CIK 0001818794 · Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364883909
- Phone
- (781) 786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- 4 Planned sale Chief Medical Officer sold 2,321 shares at an average $45.12 ($104,727)
- 4 Planned sale Chief Operating Officer sold 2,910 shares at an average $45.12 ($131,304)
- 4 Planned sale Chief Scientific Officer sold 2,636 shares at an average $45.12 ($118,939)
- 4 Planned sale Director sold 248,675 shares at an average $45.48 ($11,310,183)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 281,541 shares at an average $44.76 ($12,601,536)
- 4 Planned sale Director sold 212,477 shares at an average $42.93 ($9,121,902)
- 4/A Planned sale Director sold 183,834 shares at an average $42.85 ($7,877,091)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Planned sale Director sold 183,834 shares at an average $42.85 ($7,877,091)
- 144 Insider Sale of Securities
- 4/A Planned sale Chief Operating Officer sold 40,000 shares at an average $35.09 ($1,403,668)
- 4 Planned sale Chief Operating Officer sold 39,950 shares at an average $35.09 ($1,401,902)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Operating Officer sold 40,000 shares at an average $33.36 ($1,334,201)
Page 19 of 40 · 796 filings